References
- Lehman A, Steinwachs D (1998) Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull 24: 1 — 10.
- Potkin S, Albers L, Richmond G (1993) Schizophrenia: an overview of pharmacological treatment. In: Dunner D (ed.) Current psychiatric therapy. Philadelphia, PA: WB Saunders: 142–54.
- Shiloh R, Nutt D, Weizman A (2000) Antipsychotics. In: Atlas of psychiatric pharmacotherapy. London: Martin Dunitz: 48–57.
- Dixon L, Lehman A, Levine J (1995) Conventional antipsychotic medications for schizophrenia. Schizophr Bull 21: 567—77.
- Altamura A, Mauri M, Mantero M et al (1987) Clonazepam/ haloperidol combination therapy in schizophrenia: a double blind study. Acta Psychiatr Scand 76: 702–6.
- Berk M, Ichim C, Brooks S (2001) Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Int Clin Psychopharmacol 16: 87–92.
- Hayashi T, Yokota N, Takahashi T et al (1997) Benefits of trazodone and mianserin for patients with late-life chronic schizophrenia and tardive dyskinesia: an add-on, double-blind, placebo-controlled study. Int Clin Psychopharmacol 12: 199–205.
- Joffe G, Appelberg B, Rimon R (1999) Adjunctive nefazodone in neuroleptic-treated schizophrneic patients with predominantly negative symptoms: an open-label prospective pilot study. Int Clin Psychopharmacol 14: 233–8.
- Johns C, Thompson J. Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy (1995) Schizophr Bull 21: 607–619.
- Mizuki Y, Kajimura N, Kai S et al (1992) Effects of mianserin in chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 16: 517—28.
- Rosenberg P, Rosse R, Schwartz B, Deutch S (2000) Nefazodone in the adjunctive therapy of schizophrenia: an open-label exploratory study. Clin Neuropharmacol 23: 222–5.
- Shiloh R, Zemishlany Z, Aizenberg D et al (2002) Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophrenia. Int Clin Psychopharmacol 17: 59–64.
- Peuskens J (1999) The evolving definition of treatment resistance. J Clin Psychiatry 12: 4–8.
- Overall J, Gorham D (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10: 799–812.
- Kiernan R, Mueller J, Langston J, Dyke CV (1987) The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med 107: 481—5.
- Taylor D, Mir S, Mace S et al (2002) Co-prescribing of atypical and typical antipsychotics, prescribing sequence and documented outcome. Psychiatr Bull 26: 170–2.